| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 130.34B | 123.93B | 120.39B | 114.47B | 118.70B | 121.54B |
| Gross Profit | 19.83B | 19.61B | 18.62B | 16.95B | 16.68B | 15.85B |
| EBITDA | 10.21B | 9.65B | 8.81B | 7.72B | 7.74B | 5.49B |
| Net Income | 4.96B | 4.76B | 4.56B | 3.82B | 3.87B | 2.36B |
Balance Sheet | ||||||
| Total Assets | 180.58B | 183.21B | 168.21B | 154.61B | 153.51B | 147.59B |
| Cash, Cash Equivalents and Short-Term Investments | 20.06B | 21.58B | 23.77B | 20.31B | 19.64B | 20.33B |
| Total Debt | 107.38B | 108.71B | 95.87B | 88.85B | 89.09B | 88.39B |
| Total Liabilities | 124.68B | 128.54B | 117.21B | 107.52B | 109.16B | 106.10B |
| Stockholders Equity | 55.90B | 54.67B | 51.00B | 47.08B | 44.35B | 41.49B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -13.39B | -2.22B | 2.41B | -1.49B | 22.40B |
| Operating Cash Flow | 0.00 | 2.74B | 5.99B | 9.00B | 6.32B | 28.04B |
| Investing Cash Flow | 0.00 | -16.29B | -8.20B | -6.62B | -6.33B | -5.13B |
| Financing Cash Flow | 0.00 | 11.36B | 5.67B | -1.72B | -518.39M | -17.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥51.90B | 8.51 | ― | 3.64% | 15.82% | 22.32% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥41.20B | 9.84 | ― | 0.45% | -8.33% | -36.89% | |
62 Neutral | ¥29.22B | 7.18 | ― | 4.20% | 6.26% | -4.41% | |
62 Neutral | ¥68.48B | 8.53 | ― | 2.89% | -3.09% | -35.66% | |
62 Neutral | ¥22.00B | -32.07 | ― | 3.54% | 36.88% | 83.47% | |
60 Neutral | ¥66.85B | 9.58 | ― | 5.71% | 8.07% | 12.06% |